« Previous
Next »
American Journal of Ophthalmology
Volume 127, Issue 4
, Pages 426-435
, April 1999
Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14
References
-
.
[Fundus flavimaculatus of dominant heredity (apropos of 2 families). Nosological considerations on Stargardt’s disease.].
Bulletin des Soc d Ophtalmol de France. 1975;75:309–315
- . Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol. 1980;98:1785–1789
- . Dominant inheritance of Stargardt’s disease. J Am Optom Assoc. 1988;59:112–117
- . Long-term follow-up of dominant macular dystrophy with flecks (Stargardt). Ophthalmologica. 1992;205:138–143
- . Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. [see comments] Arch Ophthalmol. 1994;112:765–772
-
Krill AE. Flecked retina diseases. In: Krill AE, editor. Krill’s hereditary retinal and choroidal diseases. Hagerstown, Maryland: Harper and Row, 1977:750, 762.
- . A dominant Stargardt’s macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol. 1994;112:759–764
- . Ueber familiare, progressive degeneration in der makulagegend des auges. Graefes Arch Clin Exp Ophthalmol. 1909;71:534–550
-
.
The hereditary dystrophies of the posterior pole of the eye. Assen, The Netherlands: Royal VanGorcum Ltd; 1971;
-
.
Ueber familiare, progressive degeneration in der makulagegend des auges.
Z Augenheilk. 1913;30:95–115
-
.
Les heredo-degenerescences chorio-retiniennes. Paris: Masson; 1963;
- . Pattern dystrophy of the pigment epithelium. Am J Ophthalmol. 1977;84:32–44
- . Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;111:1531–1542
- Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. [see comments] Science. 1997;277:1805–1807
- Age-related macular degeneration (clinical features in a large family and linkage to chromosome 1q). Arch Ophthalmol. 1998;116:1082–1088
- . Autosomal-dominant fundus flavimaculatus (clinicopathologic correlation). Ophthalmology. 1990;97:798–809
-
.
Sorsby fundus dystrophy (reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation).
Arch Ophthalmology. 1997;115:1569–1571
- An ancestral core haplotype defines the critical region harbouring the North Carolina macular dystrophy gene (MCDR1). J Med Genet. 1997;34:961–966
- . A computer program for linkage analysis of general human pedigrees. Am J Hum Genet. 1976;28:528–529
- A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. [see comments] Nature Genetics. 1997;15:236–246
- . Clinical study of a large family with autosomal dominant progressive cone degeneration. Am J Ophthalmol. 1996;121:1–12
- . Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet. 1990;85:635–642
- A YAC contig encompassing the recessive Stargardt disease gene (STGD) on chromosome 1p. Am J Hum Genet. 1995;57:1351–1363
- . Mapping of autosomal dominant cone degeneration to chromosome 17p. Am J Ophthalmol. 1996;121:13–138
- . X-shaped macular dystrophy with flavimaculatus flecks. Ophthalmologica. 1989;199:146–157
-
.
Flecked retina diseases.
In:
Krill AE editors. Krill’s hereditary retinal and choroidal diseases. New York: Harper and Row; 1977;p. 739–824
- . North Carolina macular dystrophy and central areolar pigment epithelial dystrophy. One family, one disease. Arch Ophthalmol. 1992;110:515–518
- Sorsby’s fundus dystrophy in the British Isles (demonstration of a striking founder effect by microsatellite-generated haplotypes). Genome Research. 1996;6:92–101
☆ Supported by the Elizabeth C. King Trust, the Ruben and Mollie Gordon Foundation, the Eye Research Institute, the Estates of Betty Gross, Margaret Mercer, and Martha W. S. Rogers, and an unrestricted grant from Research to Prevent Blindness, Inc, New York, New York, and Macular Degeneration International at the Wills Eye Hospital, Philadelphia, Pennsylvania. The Kyle Curran Fund, an unrestricted grant from Research to Prevent Blindness, Inc, the Foundation Fighting Blindness (Dr Weleber), and the Heed Ophthalmic Foundation (Dr Edwards) provided support at the Casey Eye Institute.
PII: S0002-9394(98)00331-6
© 1999 Elsevier Science Inc. All rights reserved.
« Previous
Next »
American Journal of Ophthalmology
Volume 127, Issue 4
, Pages 426-435
, April 1999
